Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
J Vis Exp ; (205)2024 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-38526120

RESUMO

Animal models remain necessary tools to study neuropathic pain. This manuscript describes the distal infraorbital nerve chronic constriction injury (DIoN-CCI) model to study trigeminal neuropathic pain in mice. This includes the surgical procedures to perform the chronic constriction injury and the postoperative behavioral tests to evaluate the changes in spontaneous and evoked behavior that are signs of ongoing pain and mechanical allodynia. The methods and behavioral readouts are similar to the infraorbital nerve chronic constriction injury (IoN-CCI) model in rats. However, important changes are necessary for the adaptation of the IoN-CCI model to mice. First, the intra-orbital approach is replaced by a more rostral approach with an incision between the eye and the whisker pad. The IoN is thus ligated distally outside the orbital cavity. Secondly, due to the higher locomotor activity in mice, allowing rats to move freely in small cages is replaced by placing mice in custom-designed and constructed restraining devices. After DIoN ligation, mice exhibit changes in spontaneous behavior and in response to von Frey hair stimulation that are similar to those in IoN-CCI rats, i.e., increased directed face grooming and hyperresponsiveness to von Frey hair stimulation of the IoN territory.


Assuntos
Neuralgia , Neuralgia do Trigêmeo , Ratos , Camundongos , Animais , Constrição , Ratos Sprague-Dawley , Neuralgia do Trigêmeo/cirurgia , Nervo Maxilar/lesões , Neuralgia/etiologia , Hiperalgesia/etiologia , Modelos Animais de Doenças , Nervo Trigêmeo
2.
Clin Neurol Neurosurg ; 166: 36-43, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29408770

RESUMO

OBJECTIVE: To describe the patient's self assessed health related quality of life (saHRQoL) based upon the medical outcome study 36-item short form health survey (SF-36) as well as the factors of influence upon the saHRQoL following surgery for petroclival (PCM) and lateral posterior surface of the pyramid (LPPM) meningiomas. PATIENTS AND METHODS: In a series of 78 patients operated consecutively for PCM (n = 46) or LPPM (n = 32) the preoperative, intraoperative and postoperative data were collected retrospectively. The saHRQoL was obtained by mailing the SF-36 questionnaire to the patients. The SF-36 data of the whole patients group was compared with a healthy population. The SF-36 data of the PCM- and LPPM were compared to each other. The influence of pre-, intra- and postoperative findings upon the SF-36 was assessed by uni- and multifactorial analysis. RESULTS: 58 (69%) out of the 78 patients answered the SF-36 questionnaire at a median postoperative follow-up of 59 months. The patients, who answered the SF-36 questionnaire, had a significant lower perioperative complication rate than those who did not (46% vs. 75%, p = 0.019). The saHRQoL of the LPPM and PCM was reduced on several sub-scales, when compared to the German reference population. The outcome of PCM is, assessed by saHRQoL as well as by conventional neurosurgical grading scales, inferior to that of LPPM. The saHRQoL of LPPM correlated in the uni- and multivariate analysis with the early postoperative KPI on the sub-scales SF1 (physical functioning) and SF5 (vitality). Accordingly, the sub-scale SF2 (role-physical) of PCM correlated with the change of the KPI from preoperative to the last follow up. CONCLUSIONS: The saHRQoL of the evaluable patients was lower than that of the normal population. The saHRQoL score of PCM-patients was lower than that of LPPM-patients. For the future the saHRQol should be assessed routinely; It reflects the patients' perspective upon postoperative outcome and enables the comparison with other treatment modalities of these difficult to treat tumors.


Assuntos
Fossa Craniana Posterior/cirurgia , Neoplasias Meníngeas/cirurgia , Osso Petroso/cirurgia , Qualidade de Vida , Neoplasias da Base do Crânio/cirurgia , Inquéritos e Questionários , Adulto , Idoso , Idoso de 80 Anos ou mais , Fossa Craniana Posterior/diagnóstico por imagem , Feminino , Seguimentos , Humanos , Masculino , Neoplasias Meníngeas/diagnóstico por imagem , Neoplasias Meníngeas/psicologia , Pessoa de Meia-Idade , Osso Petroso/diagnóstico por imagem , Qualidade de Vida/psicologia , Estudos Retrospectivos , Neoplasias da Base do Crânio/diagnóstico por imagem , Neoplasias da Base do Crânio/psicologia , Inquéritos e Questionários/normas , Resultado do Tratamento
3.
Clin Neurol Neurosurg ; 141: 122-8, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26826961

RESUMO

OBJECTIVE: The goal of this study was to determine the impact of the location of the most frequent skull base meningioma of the posterior fossa, i.e. petroclival (PCM) and lateral posterior pyramid meningioma (LPPM) on clinical presentation, surgical treatment and treatment results. PATIENTS AND METHODS: We retrospectively reviewed a consecutive series of patients operated on for PCM (n=46) and LPPM (n=32). Uni- and multivariate analyses were performed to identify differences in clinical presentation, surgical treatment and pre-, intra- and postoperative factors of influence upon the outcome parameters: Complications rate, mortality, tumour recurrence/progress, hospital stay, Karnofsky Performance Score (KPS). RESULTS: At Presentation, the rate of dizziness was higher in LPPM (56% vs. 7%, p<0,001) and trigeminal nerve impairment was more frequent in PCM (50% vs. 3%, p<0,001). Complete tumour resections were more often achieved (91% vs. 39%, p<0,001), and surgery lasted shorter (median: 247 min vs. 500 min, p<0,001) with less blood loss (median: 525 ml vs. 1000 ml, p<0,001) in LPPM compared to PCM. The overall complication rates (73% vs. 31%, p<0,001) as well the rate of irreversible complications (57% vs. 9%, p<0,004) were higher in PCM than in LPPM. The most frequent complications of PCM surgery were eye movement (46% vs. 6%, p<0,001), facial nerve (28% vs. 3%, p<0.02) and swallowing impairments (21% vs. 3%, p<0.02). The perioperative mortality was 11% in PCM and 0% in LPPM patients. In the multivariate analyses, KPS at discharge correlate positively with age (p=0.034) and preoperative KPS (p=0.0048) in LPPM and positively with staged resection (p=0.056) and negatively with the occurrence of surgical complications (p=0,0427) in PCM. Hospitalization time correlated with the blood loss (p<0,001) for PCM, negatively with the preoperative KPS (p=0.0002) for PCM and LPPM and positively with tumour diameter (p=0.0001) and non-surgical complications rate (p=0.0001) for LPPM. CONCLUSION: As compared to LPPM, surgical treatment of PCM is associated with higher morbidity and mortality. The outcome of LPPM was primarily influenced by preoperative factors: Patients age, tumour size, preoperative KPS. The outcome of PCM was primarily influenced by intraoperative factors like: blood loss, surgery duration, staged tumour resection and the surgical complications rate.


Assuntos
Fossa Craniana Posterior/cirurgia , Complicações Intraoperatórias , Neoplasias Meníngeas/cirurgia , Meningioma/cirurgia , Neoplasias da Base do Crânio/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Fossa Craniana Posterior/patologia , Feminino , Humanos , Complicações Intraoperatórias/diagnóstico , Complicações Intraoperatórias/mortalidade , Masculino , Neoplasias Meníngeas/diagnóstico , Neoplasias Meníngeas/mortalidade , Meningioma/diagnóstico , Meningioma/mortalidade , Pessoa de Meia-Idade , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/mortalidade , Estudos Retrospectivos , Neoplasias da Base do Crânio/diagnóstico , Neoplasias da Base do Crânio/mortalidade , Resultado do Tratamento
4.
Int Ophthalmol ; 35(4): 603-9, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25989873

RESUMO

The purpose of this study was to compare the efficacy of intravitreal aflibercept versus ranibizumab for treating therapy-resistant diabetic macular oedema (DME). A 69-year-old man presented with persistent bilateral DME despite previous ranibizumab treatment. Bilateral study treatment comprised one cycle of three monthly ranibizumab injections (0.5 mg), followed by one cycle of three aflibercept injections (2.0 mg), a second ranibizumab cycle and a second aflibercept cycle. Baseline visual acuity (ETDRS score) was 60 letters for the right eye and 65 letters for the left eye. Baseline central foveal thickness (CFT) was 305 µm for the right eye and 453 µm for the left eye. Substantially improved outcomes were observed during the first aflibercept cycle. CFT was reduced by 150 µm (mean) in both the eyes and decreased below the lowest level achieved during the previous 2.5-year ranibizumab treatment. Visual acuity was improved by 17.5 letters (mean) in both the eyes. Reintroduction of ranibizumab immediately worsened the status of both eyes back to the baseline level. During the final aflibercept cycle, visual acuity and CFT improved to the same levels achieved during the first aflibercept cycle. In this case study, we prospectively switched the treatment three times and observed a dramatic and consistent treatment advantage for aflibercept.


Assuntos
Inibidores da Angiogênese/uso terapêutico , Retinopatia Diabética/tratamento farmacológico , Fatores Imunológicos/uso terapêutico , Edema Macular/tratamento farmacológico , Ranibizumab/uso terapêutico , Receptores de Fatores de Crescimento do Endotélio Vascular/uso terapêutico , Proteínas Recombinantes de Fusão/uso terapêutico , Idoso , Estudos Cross-Over , Humanos , Injeções Intravítreas , Masculino , Estudos Prospectivos , Acuidade Visual
5.
PLoS One ; 9(6): e101087, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24972036

RESUMO

BACKGROUND: Infection-related exacerbations of respiratory diseases are a major health concern; thus understanding the mechanisms driving them is of paramount importance. Despite distinct inflammatory profiles and pathological differences, asthma and COPD share a common clinical facet: raised airway ATP levels. Furthermore, evidence is growing to suggest that infective agents can cause the release of extracellular vesicle (EVs) in vitro and in bodily fluids. ATP can evoke the P2X7/caspase 1 dependent release of IL-1ß/IL-18 from EVs; these cytokines are associated with neutrophilia and are increased during exacerbations. Thus we hypothesized that respiratory infections causes the release of EVs in the airway and that the raised ATP levels, present in respiratory disease, triggers the release of IL-1ß/IL-18, neutrophilia and subsequent disease exacerbations. METHODS: To begin to test this hypothesis we utilised human cell-based assays, ex vivo murine BALF, in vivo pre-clinical models and human samples to test this hypothesis. RESULTS: Data showed that in a murine model of COPD, known to have increased airway ATP levels, infective challenge causes exacerbated inflammation. Using cell-based systems, murine models and samples collected from challenged healthy subjects, we showed that infection can trigger the release of EVs. When exposed to ATP the EVs release IL-1ß/IL-18 via a P2X7/caspase-dependent mechanism. Furthermore ATP challenge can cause a P2X7 dependent increase in LPS-driven neutrophilia. CONCLUSIONS: This preliminary data suggests a possible mechanism for how infections could exacerbate respiratory diseases and may highlight a possible signalling pathway for drug discovery efforts in this area.


Assuntos
Asma/metabolismo , Micropartículas Derivadas de Células/metabolismo , Doença Pulmonar Obstrutiva Crônica/metabolismo , Infecções Respiratórias/metabolismo , Trifosfato de Adenosina/farmacologia , Animais , Asma/complicações , Caspases/metabolismo , Linhagem Celular Tumoral , Micropartículas Derivadas de Células/efeitos dos fármacos , Micropartículas Derivadas de Células/ultraestrutura , Humanos , Interleucina-18/metabolismo , Interleucina-1beta/metabolismo , Lipopolissacarídeos/toxicidade , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Doença Pulmonar Obstrutiva Crônica/complicações , Receptores Purinérgicos P2X7/metabolismo , Infecções Respiratórias/complicações
6.
Clin Neuroradiol ; 20(2): 99-107, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20490439

RESUMO

BACKGROUND AND PURPOSE: Streak artifacts caused by aneurysm clips and coils impede image quality in multidetector computed tomography (MDCT). The authors propose a technique to minimize these artifacts by gated data reconstruction and shifting the reconstruction window. PATIENTS AND METHODS: Intracranial CT angiograms were acquired in the follow-up of six patients with clipped and coiled intracranial aneurysms, respectively. Images were reconstructed from four consecutive 45 degrees rotated segments with an acquisition time of 52.5 ms/segment. Data acquisition was gated via an external pacemaker cable-connected to the scanner. RESULTS: Artifact orientation could be rotated by shifting the reconstruction window and interesting vessel segments visualized without disturbing streak artifacts. This allowed to assess the posterior communicating artery origin in two cases and a middle cerebral artery aneurysm remnant in another case, respectively. However, due to a higher noise interesting vessel segments were not adjustable in another three patients. CONCLUSION: Gated MDCT is a promising technique to reduce the amount and to change the position of artifacts induced by clips or coils.


Assuntos
Artefatos , Prótese Vascular , Aneurisma Intracraniano/diagnóstico por imagem , Aneurisma Intracraniano/cirurgia , Técnicas de Imagem de Sincronização Respiratória/métodos , Instrumentos Cirúrgicos , Tomografia Computadorizada por Raios X/métodos , Idoso , Angiografia Cerebral/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Intensificação de Imagem Radiográfica/métodos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
7.
AJNR Am J Neuroradiol ; 31(1): 100-5, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19713322

RESUMO

BACKGROUND AND PURPOSE: CSF loss with consecutive intracranial hypotension has been discussed as a possible pathogenetic mechanism in poor clinical outcome after uneventful neurosurgery and appears to be correlated to specific imaging findings. The purpose of this study was to describe the clinical and imaging findings of symptomatic intracranial hypotension likely induced by wound suction drainage. MATERIALS AND METHODS: This is a review of previously published cases of patients in whom this condition developed after uneventful intracranial surgery. We performed an analysis of 3 more cases, of which 2 occurred after spinal surgery with accidental dural opening. RESULTS: Sixteen patients who remained unconscious or did not become fully responsive after surgery showed symmetric bilateral thalamic/basal ganglia signal intensity changes on CT and MR imaging studies. Of these 16 patients, 4 died and 2 also had brain stem signal intensity changes. All patients had rapid and distinct intraoperative and postoperative CSF loss documented on CT and/or MR imaging studies by a transient increase of the sag ratio, defined as maximal anteroposterior midbrain diameter by maximal bipeduncular diameter. CONCLUSIONS: The clinical course and typical MR imaging findings characterize the disease entity postsurgical intracranial hypotension. These findings also underline the potential danger of wound suction drainage in the case of possible CSF loss.


Assuntos
Angiografia Digital , Hipotensão Intracraniana/diagnóstico , Imageamento por Ressonância Magnética , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Hipotensão Intracraniana/etiologia , Masculino , Pessoa de Meia-Idade , Procedimentos Neurocirúrgicos/efeitos adversos , Prognóstico
8.
Cent Eur Neurosurg ; 70(3): 149-53, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19701874

RESUMO

We present a rare case of a metastasis to a pituitary adenoma and review 14 cases published in the literature to date. Metastases to pituitary adenomas most commonly present with rapidly progressing chiasm compression syndromes, headaches and oculomotor nerve palsies. The prognosis for this condition is poor. Metastases to pituitary adenomas have to be considered in the differential diagnosis of sellar tumors.


Assuntos
Adenoma Hipofisário Secretor de ACT/patologia , Adenoma Hipofisário Secretor de ACT/secundário , Neoplasias Hipofisárias/patologia , Neoplasias Hipofisárias/secundário , Adenoma Hipofisário Secretor de ACT/cirurgia , Idoso , Antineoplásicos/uso terapêutico , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/secundário , Evolução Fatal , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/patologia , Imageamento por Ressonância Magnética , Masculino , Metástase Neoplásica/patologia , Nervo Oculomotor/patologia , Oftalmoplegia/etiologia , Neoplasias Hipofisárias/cirurgia , Carcinoma de Pequenas Células do Pulmão/patologia , Tomografia Computadorizada por Raios X
9.
Acta Neurochir (Wien) ; 150(4): 329-35; discussion 335, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18309452

RESUMO

BACKGROUND: We set out to prospectively study the peri-operative changes of the hypothalamic-pituitary-adrenal axis (HPA), and to test the hypothesis that the peri-operative corticoid replacement regimen used at the authors' institution in patients with impaired HPA undergoing transsphenoidal pituitary adenoma surgery is adequate. METHOD: Thirty seven patients (21 females, 16 males, mean age 50.6 years) underwent transsphenoidal pituitary adenoma surgery (mean tumour diameter 20.6 mm, 13 tumours hormone-secreting). The HPA functions of these patients were classified as impaired (group A, n = 15) or preserved (group B, n = 22) according to the results of a pre-operative corticotrophin releasing-hormone test (CRHT). Eleven patients (9 female, 2 male, mean age 53.6 years) without pituitary adenomas and with a preserved HPA (as assessed by medical history and morning serum cortisol (MSC) measurements), undergoing decompressive surgery for degenerative lumbar disc disease, were also studied (group C). On the day of surgery, the patients of group A received 100 mg hydrocortisone (HC) replacement therapy, which was thereafter gradually tapered off in a standardised fashion. The patients of groups B and C were not treated with corticoids. Pre-operative, intra-operative and post-operative variables of these three patient groups were compared. FINDINGS: The urinary free cortisol excretion (UFC) in group A declined from 6732 +/- 7683 microg/d on the day of surgery to 305 +/- 358 microg/d on the 10(th) post-operative day. In group B, the respective UFC values were 12,851 +/- 16,278 microg/d and 223 +/- 235 microg/d. In both of these groups, the mean UFC did not fall into the normal range during the first ten post-operative days. On none of the post-operative days, was there a significant difference between the UFC of groups A and B. The UFC values of group C dropped from 177 +/- 157 microg/d on the day of surgery to 87 +/- 61 microg/d on post-operative day six, reaching the normal range from the 2(nd) post-operative day onwards. All UFC values of group C were significantly lower than those of group A and B. None of the evaluated clinical, laboratory and MRI parameters, as disclosed by uni- and multivariate analysis, showed any significant influence on the peri-operative UFC values. CONCLUSIONS: The peri-operative UFC of pituitary adenoma patients with preserved HPA was very high, as compared to patients with degenerative lumbar disc disease. The present study showed for the first time, that the proposed regimen of peri-operative corticoid replacement therapy used in patients with pituitary adenomas and impaired HPA raised cortisol levels to match the physiological increase of UFC in patients with pituitary adenoma surgery and preserved HPA. However, although statistically not significant, the UFC of patients with pituitary adenomas and preserved HPA seemed considerably higher on the day of surgery than in patients with pituitary adenomas and HPA impairment. Although there is no evidence to make it mandatory, administration of 150 mg instead of 100 mg HC substitution on the day of pituitary adenoma surgery in patients with HPA impairment may be prudent.


Assuntos
Hidrocortisona/administração & dosagem , Hipofisectomia , Neoplasias Hipofisárias/cirurgia , Seio Esfenoidal/cirurgia , Hormônio Liberador da Corticotropina , Descompressão Cirúrgica , Relação Dose-Resposta a Droga , Esquema de Medicação , Humanos , Hidrocortisona/sangue , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/fisiopatologia , Deslocamento do Disco Intervertebral/fisiopatologia , Deslocamento do Disco Intervertebral/cirurgia , Vértebras Lombares/fisiopatologia , Vértebras Lombares/cirurgia , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/fisiopatologia , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Sistema Hipófise-Suprarrenal/fisiopatologia , Pré-Medicação , Estudos Prospectivos , Valores de Referência , Compressão da Medula Espinal/fisiopatologia , Compressão da Medula Espinal/cirurgia
10.
Zentralbl Neurochir ; 68(3): 142-4, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17665343

RESUMO

The selective transsphenoidal adenomectomy of an ACTH-secreting microadenoma was followed by clinically symptomatic delayed hyponatremia in an otherwise healthy patient. During mild fluid restriction for the treatment of the hyponatremia, acute renal failure occurred. The renal failure was resolved by treatment with furosemide. Fluid restriction is considered a standard therapeutic approach for the treatment of this probably SIADH-induced hyponatremia. Until now, acute renal failure has not been reported under these circumstances. This unique case demonstrates the need of close monitoring of patients with delayed hyponatremia following pituitary surgery.


Assuntos
Adenoma Hipofisário Secretor de ACT/cirurgia , Injúria Renal Aguda/etiologia , Adenoma/cirurgia , Hiponatremia/etiologia , Complicações Pós-Operatórias/metabolismo , Adenoma Hipofisário Secretor de ACT/complicações , Injúria Renal Aguda/metabolismo , Adenoma/complicações , Adulto , Pressão Sanguínea , Peso Corporal , Feminino , Hidratação , Humanos , Hiponatremia/metabolismo , Testes de Função Renal , Procedimentos Neurocirúrgicos , Urodinâmica , Equilíbrio Hidroeletrolítico/fisiologia
11.
Eur J Pain ; 8(6): 547-54, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15531223

RESUMO

F 13640 is a recently discovered high-efficacy 5-HT1A receptor agonist that has demonstrated robust anti-allodynic efficacy in a rat model of trigeminal neuropathic pain upon acute and continuous administration. In this model, continuous morphine infusion (5 mg/day) was shown to be effective during the first week of its administration but became almost completely ineffective by the end of the second week; F 13640's effectiveness (0.63 mg/day) remained unchanged during two weeks. Here, we examined the effects of combining F 13640 infusion with that of morphine. During the first week, the combination of the two agents produced a magnitude of effect that was similar to that of morphine when given alone and larger than that of F 13640 alone. During the second week, the combination produced an effect that was similar to that of F 13640 alone, and more effective than that of morphine alone. The latter data suggest that the 5-HT1A agonist, F 13640, inhibits the development of tolerance to morphine in this model. However, it is also possible that little, if any, interaction occurred between the different mechanisms initiated by opioid and 5-HT1A receptor activation, and that the anti-allodynic effect that remained by the end of the two-week treatment period is due solely to 5-HT1A receptor activation. The stable effects of F 13640 during the second week of treatment surpassed those of morphine and were not improved by the addition of morphine to F 13640.


Assuntos
Analgésicos Opioides/uso terapêutico , Morfina/uso terapêutico , Piperidinas/uso terapêutico , Piridinas/uso terapêutico , Receptor 5-HT1A de Serotonina/efeitos dos fármacos , Agonistas do Receptor de Serotonina/uso terapêutico , Neuralgia do Trigêmeo/tratamento farmacológico , Aminopiridinas/farmacologia , Animais , Comportamento Animal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Quimioterapia Combinada , Tolerância a Medicamentos , Bombas de Infusão Implantáveis , Masculino , Medição da Dor/efeitos dos fármacos , Estimulação Física , Piperidinas/farmacologia , Ratos , Ratos Sprague-Dawley
12.
Exp Clin Endocrinol Diabetes ; 112(6): 323-7, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15216450

RESUMO

AIM: To study improvement of anterior pituitary function after transsphenoidal and transcranial surgery of non-functioning (NF) pituitary macro- and microadenomas. METHODS: We retrospectively examined 155 patients with NF adenomas preoperatively and 3 months, 1 year and 2 years postoperatively. 130 patients harboured a macroadenoma, 109 underwent transsphenoidal (group one), 21 transcranial surgery (group two). 25 patients presented a microadenoma (transsphenoidal surgery, group three). Endocrine studies included basal serum levels and dynamic testing of anterior pituitary partial function. Clinical symptoms and hormone replacement therapy were documented. RESULTS: Preoperatively, in group one, two and three, somatotropic function was impaired in 85, 90 and 80 %, gonadotropic in 61, 57 and 24 %, corticotropic in 31, 38 and 28 %, thyreotropic in 32, 38 and 12 % and lactotropic in 22, 38 and 32 % cases, respectively. Pituitary functions did not improve significantly after transsphenoidal or transcranial surgery. Presurgically, 63, 62 and 0 % patients complained about visual impairments, 60, 48 and 40 % about headache, 53, 24 and 36 % about fatigue and 28, 33 and 20 % about disturbance of cycle or potency. After transsphenoidal surgery, impaired vision, headache and fatigue improved within 3 months; after transcranial surgery, only headache improved. Preoperatively, pituitary malfunctions were treated adequately. Postsurgically, more patients received adrenal and thyroid hormone substitution, less patients received sex hormones than examinations proved necessary. CONCLUSION: Anterior pituitary function of NF adenoma patients did not improve significantly after transsphenoidal or transcranial surgery. After transsphenoidal surgery, most clinical symptoms normalised within 3 months. In some of the patients, substitution was not optimally adjusted to hormonal impairments.


Assuntos
Adenoma/cirurgia , Hormônios/fisiologia , Neoplasias Hipofisárias/cirurgia , Procedimentos Cirúrgicos Operatórios/métodos , Corticosteroides/administração & dosagem , Adulto , Feminino , Hormônios Esteroides Gonadais/administração & dosagem , Terapia de Reposição Hormonal , Humanos , Masculino , Pessoa de Meia-Idade , Hipófise/fisiopatologia , Neoplasias Hipofisárias/fisiopatologia , Estudos Retrospectivos , Crânio , Osso Esfenoide , Seio Esfenoidal , Hormônios Tireóideos/administração & dosagem , Resultado do Tratamento
13.
Acta Neurochir (Wien) ; 144(6): 555-61; discussion 561, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12111488

RESUMO

BACKGROUND: To study remission rates and pituitary functions following transsphenoidal surgery of newly diagnosed GH-, ACTH-, and PRL-secreting pituitary adenomas. METHODS: Out of a series of 329 newly diagnosed pituitary adenomas, 131 (39.8%) were hormone (67 GH-, 27 ACTH-, 37 PRL-) secreting. PRL-secreting adenomas were subjected to surgery because they failed to respond to previous medical treatment therapy. The data on secreting adenomas, regarding the results of standardised endocrinological testing, MRI findings and water metabolism disturbances, were extracted retrospectively from the pituitary data-base of the hospital. The mean follow-up was 3.7 years. RESULTS: The overall remission rate for PRL-secreting adenomas (27%) was significantly lower than for GH- (71.6%) and ACTH-secreting (81.5%) ones. Remission rates correlated negatively with the magnitude of preoperative hormone excess (not in Cushing's disease), tumour size (not in prolactinoma) and invasiveness. Generally, the improvement of the adenopituitary functions was statistically significant during the first three postoperative months, and thereafter remained unchanged. Diabetes insipidus persisting for more than three months occurred with similar frequency in the three patient groups (in 9.4% of GH-, in 6.7% of ACTH-, and in 10% of PRL-secreting adenomas). Tumour regrowth occurred more often in PRL-(20%) than in ACTH- (9.1%) and GH- (0%) secreting tumours. CONCLUSIONS: In GH- and ACTH-secreting pituitary adenomas, remission rates were significantly higher and recurrence rates lower than in PRL-secreting adenomas, which had failed to respond to previous medical therapy. The overall postoperative adenopituitary function was improved in all patient groups. Diabetes insipidus occurred with similar frequency in all patient groups. When reporting on results of surgery for secreting pituitary adenomas, not only remission and recurrence rates, but also the results of the pituitary function should be included.


Assuntos
Recidiva Local de Neoplasia , Neoplasias Hipofisárias/cirurgia , Prolactinoma/cirurgia , Hormônio Adrenocorticotrópico/metabolismo , Adulto , Sistema Endócrino/fisiologia , Feminino , Seguimentos , Hormônio do Crescimento/metabolismo , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Neoplasias Hipofisárias/patologia , Prolactinoma/patologia , Osso Esfenoide/cirurgia
14.
Comp Med ; 52(1): 44-9, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11900412

RESUMO

BACKGROUND AND PURPOSE: Chronic constriction injury to the rat infraorbital nerve (IoN-CCI) was reported to induce asymmetric face grooming directed to the territory of the injured nerve, and localized mechanical allodynia. The model has been used for pharmacologic testing; responsiveness to mechanical stimulation has been used as outcome measure, but face grooming behavior was not studied in this context. METHODS: Face grooming data from a series of four experiments using the IoN-CCI model were retrospectively analyzed, and two types of face grooming were identified: on the one hand, isolated face grooming (i.e., face grooming that is neither preceded nor followed by body grooming); and on the other hand, face grooming during body grooming (i.e., face grooming that is part of more general body grooming behavior). RESULTS: In all four experiments, amount of isolated face grooming was found to be significantly increased after IoN-CCI. In contrast, the amount of face grooming during body grooming was not significantly altered after IoN-CCI in any of the four experiments. CONCLUSIONS: The amount of isolated face grooming is a more sensitive outcome measure of neuropathic pain than is the total amount of face grooming, which includes face grooming during body grooming.


Assuntos
Constrição Patológica/psicologia , Traumatismos do Nervo Facial/psicologia , Nervo Maxilar/lesões , Órbita/inervação , Dor/psicologia , Animais , Constrição Patológica/fisiopatologia , Modelos Animais de Doenças , Traumatismos do Nervo Facial/fisiopatologia , Lateralidade Funcional , Asseio Animal/fisiologia , Masculino , Nervo Maxilar/fisiopatologia , Dor/fisiopatologia , Ratos , Ratos Sprague-Dawley , Comportamento Estereotipado/fisiologia
15.
J Neurol Neurosurg Psychiatry ; 67(3): 398-402, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10449568

RESUMO

Criteria for the non-invasive diagnosis of lymphocytic hypophysitis (LyHy) and the results of the first prospective trial of high dose methylprednisolone pulse therapy (HDMPT) in nine patients are presented. In three patients, the diagnosis was established histologically, and in the others by clinical and endocrinological assessment, MRI, CSF examination, and measurement of thyroglobulin autoantibody concentration. After HDMPT, adenopituitary function improved in four of the nine patients and diabetes insipidus ceased or improved in all four concerned patients. The MRI findings improved in seven patients. LyHy has to be considered in the differential diagnosis of sellar lesions. The presumptive non-invasive diagnosis of LyHy seems possible in a high proportion of patients. HDMPT may result in the improvement of clinical, endocrinological, and MRI findings.


Assuntos
Linfócitos/patologia , Metilprednisolona/administração & dosagem , Metilprednisolona/uso terapêutico , Doenças da Hipófise/tratamento farmacológico , Adulto , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Doenças da Hipófise/patologia , Hipófise/patologia
16.
Acta Neurochir (Wien) ; 141(4): 399-405, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10352750

RESUMO

It is not clear whether the pre-operative treatment of GH-secreting pituitary adenomas with Octreotide improves the surgical remission rates of acromegaly. In a prospective controlled study the results of transsphenoidal surgery in newly diagnosed GH-secreting macro-adenomas were compared in patients with (n = 11, group A) and without (n = 13, group B) preoperative Octreotide treatment. During the treatment with a daily dosage of 470 +/- 160 micrograms Octreotide for 16.5 +/- 10 weeks, the GH- and IGF-1-values of group A dropped significantly from 38.9 +/- 34.1 to 6.8 +/- 4.9 micrograms/l and from 2.7 +/- 1 to 1.7 +/- 0.7 arbitrary units respectively. The adenoma-shrinkage from 5.9 +/- 5.8 to 4.7 +/- 4.9 cm3 missed statistical significance by little. There was no statistically significant difference between the postoperative acromegaly remission rates of 55% in group A and 69% in group B. Of the adenomas that postoperatively were not in remission, 80% in group A and 75% in group B disclosed an infiltrative growth pattern not influenced by the Octreotide pretreatment. All other patients not cured presented with initial GH-values of > 50 micrograms/l. There was no statistically significant difference between the postoperative anterior pituitary function in the two patient groups. In this study Octreotide was not beneficial in improving the results of GH-secreting pituitary macro-adenoma surgery. However, larger prospective controlled studies are needed to address this issue.


Assuntos
Acromegalia/tratamento farmacológico , Acromegalia/cirurgia , Adenoma/tratamento farmacológico , Adenoma/cirurgia , Antineoplásicos Hormonais/uso terapêutico , Octreotida/uso terapêutico , Neoplasias Hipofisárias/tratamento farmacológico , Neoplasias Hipofisárias/cirurgia , Adulto , Quimioterapia Adjuvante , Distribuição de Qui-Quadrado , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Procedimentos Neurocirúrgicos/métodos , Procedimentos Neurocirúrgicos/normas , Cuidados Pré-Operatórios/métodos , Cuidados Pré-Operatórios/normas , Estudos Prospectivos , Resultado do Tratamento
17.
Acta Neurochir (Wien) ; 141(12): 1273-9; discussion 1279-80, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10672297

RESUMO

The discussion regarding factors that reliably predict the long-term surgical results in patients with lumbar spinal stenosis is still going on. This retrospective study analyses the relation between the dimensions of the dural sac and patients' clinical status before and after decompressive operations performed with or without additional discectomy. The type of surgery performed in 134 patients and the dural sac dimensions measured on postmyelograpic computed tomography in 100 of these patients were related to the Prolo scores before surgery and at follow-up (mean 46 months). The degree of dural sac compression correlated significantly with the patients' postoperative Prolo score and with the difference between the pre- and postoperative scores. The dural sac diameters predicted outcome after surgery more reliably than the preoperative Prolo scores. There was no statistically significant difference in the outcome when comparing patients with and without additional discectomy. The results presented suggest that the relief of symptoms after decompressive surgery for lumbar spinal stenosis correlates with the degree of the dural sac compression and that the simultaneous presence of disc herniation necessitating additional discectomy does not influence the postoperative outcome. However, these results have to be confirmed by prospective studies.


Assuntos
Descompressão Cirúrgica , Discotomia , Vértebras Lombares/cirurgia , Compressão da Medula Espinal/cirurgia , Estenose Espinal/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Terapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mielografia , Exame Neurológico , Complicações Pós-Operatórias/diagnóstico , Estudos Retrospectivos , Compressão da Medula Espinal/diagnóstico , Estenose Espinal/diagnóstico , Tomografia Computadorizada por Raios X , Resultado do Tratamento
19.
J Neurol Neurosurg Psychiatry ; 64(3): 379-81, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9527154

RESUMO

An accidental high dose of intraventricular mezlocillin was given during antibiotic treatment for pneumonia in a patient admitted because of severe traumatic brain injury and occlusive hydrocephalus. Because of serial epileptic seizures not responsive to antiepileptic drug treatment, CSF exchange was performed. The CSF was drained through a ventricular catheter, while mock CSF was infused into the lumbar subarachnoid space. The patient soon recovered to her clinical status previous to intraventricular mezlocillin application. Side effects of CSF exchange were not seen. Under continued antiepileptic medication no more seizures occurred. It is concluded that high doses of intraventricular mezlocillin have proconvulsive effects. In this patient CSF exchange was a suitable means of preventing putatively permanent impairment of brain function caused by serial epileptic seizures due to intraventricular mezlocillin application.


Assuntos
Drenagem/métodos , Epilepsia/induzido quimicamente , Epilepsia/terapia , Hidrocefalia/complicações , Erros de Medicação , Mezlocilina/intoxicação , Penicilinas/intoxicação , Pneumonia/tratamento farmacológico , Ventriculostomia , Adulto , Traumatismos Craniocerebrais/complicações , Drenagem/instrumentação , Monitoramento de Medicamentos , Overdose de Drogas , Epilepsia/líquido cefalorraquidiano , Feminino , Humanos , Hidrocefalia/diagnóstico por imagem , Hidrocefalia/terapia , Injeções Intraventriculares , Pneumonia/complicações , Tomografia Computadorizada por Raios X
20.
Surg Neurol ; 48(2): 175-83, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9242245

RESUMO

BACKGROUND: The vascular malformations of the brain have been classified into arteriovenous, venous, cavernous, and capillary malformations as four discrete entities. Various combinations of two discrete malformations in one lesion have been reported, some of which can be considered as established associations, while others appear to be very rare. Mixed vascular malformations evoke reflections on possible interrelations in the pathogenesis of the discrete components. CASE DESCRIPTIONS: We report a case of intracerebral capillary telangiectasia associated with a venous malformation in a supratentorial paraventricular location in a 45-year-old woman with a history of headache. The capillary telangiectasia was diagnosed by stereotactic biopsy. Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) strongly suggested the presence of a venous malformation by demonstrating a transcerebral draining vein running through the center of the capillary telangiectasia. The association of capillary telangiectasia and venous malformation has been reported only twice before and exclusively in the posterior fossa, as opposed to the more frequent, established associations of capillary telangiectasia and cavernous malformation, and venous malformation and cavernous malformation, respectively. CONCLUSIONS: Against the background of the established associations, this rare observation possibly places capillary telangiectasias, cavernous malformations, and venous malformations within the spectrum of a single disease. The common pathogenetic role of a focal venous outflow obstruction is discussed.


Assuntos
Veias Cerebrais/anormalidades , Circulação Cerebrovascular , Malformações Arteriovenosas Intracranianas/patologia , Telangiectasia/patologia , Capilares/patologia , Veias Cerebrais/diagnóstico por imagem , Feminino , Humanos , Malformações Arteriovenosas Intracranianas/diagnóstico por imagem , Angiografia por Ressonância Magnética , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Telangiectasia/diagnóstico por imagem , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...